MRK Merck & Co., Inc.
Research report · from SEC EDGAR · close 2026-07-16
$127.63 +3.3%
$315.22B mkt cap
executive summary
Merck & Co., Inc. (MRK) is a $315.22B company. Revenue is $65.01B (+1.3% y/y) at a 28% net margin. It is profitable. Our health score is C (68/100). No major red flags on file. Held by 1 tracked funds. It funds itself; low dilution risk.
Revenue (FY)
$65.01B
+1.3% y/y
✓ No major red flags from our filing-based checks.
who's buying
Insider buys / sells
0 / 0
Cash & ST investments
$5.70B
Operating cash flow
$16.47B
Dilution shelf
active shelf
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-16 by stocktools.ai.